| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea Syndromes | 228 | 2024 | 965 | 31.420 |
Why?
|
| Sleep Apnea, Obstructive | 213 | 2024 | 1838 | 25.920 |
Why?
|
| Sleep | 285 | 2024 | 4619 | 18.920 |
Why?
|
| Polysomnography | 256 | 2024 | 1787 | 16.020 |
Why?
|
| Actigraphy | 82 | 2023 | 490 | 9.850 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 68 | 2024 | 1019 | 9.320 |
Why?
|
| Atherosclerosis | 56 | 2024 | 3480 | 7.320 |
Why?
|
| Tonsillectomy | 22 | 2024 | 259 | 5.640 |
Why?
|
| Snoring | 37 | 2024 | 194 | 5.500 |
Why?
|
| Continuous Positive Airway Pressure | 41 | 2024 | 560 | 5.310 |
Why?
|
| Adenoidectomy | 23 | 2024 | 161 | 5.150 |
Why?
|
| Sleep Deprivation | 42 | 2023 | 815 | 5.030 |
Why?
|
| Disorders of Excessive Somnolence | 25 | 2024 | 270 | 4.350 |
Why?
|
| Hypertension | 67 | 2024 | 8614 | 3.610 |
Why?
|
| Cardiovascular Diseases | 93 | 2024 | 15433 | 3.450 |
Why?
|
| Genome-Wide Association Study | 92 | 2024 | 12432 | 2.930 |
Why?
|
| Sleep, REM | 17 | 2022 | 595 | 2.590 |
Why?
|
| Sleep Medicine Specialty | 9 | 2019 | 70 | 2.530 |
Why?
|
| Male | 579 | 2024 | 354311 | 2.430 |
Why?
|
| Humans | 879 | 2024 | 752741 | 2.430 |
Why?
|
| Circadian Rhythm | 38 | 2023 | 2557 | 2.420 |
Why?
|
| Self Report | 50 | 2023 | 3618 | 2.400 |
Why?
|
| Blood Pressure | 53 | 2024 | 8635 | 2.370 |
Why?
|
| Female | 556 | 2024 | 385090 | 2.220 |
Why?
|
| Sleep Stages | 34 | 2023 | 677 | 2.180 |
Why?
|
| Aged | 365 | 2024 | 165629 | 2.160 |
Why?
|
| Cross-Sectional Studies | 154 | 2024 | 25454 | 2.150 |
Why?
|
| Obesity | 72 | 2024 | 12868 | 2.150 |
Why?
|
| Body Mass Index | 107 | 2024 | 12821 | 2.100 |
Why?
|
| Osteoporotic Fractures | 14 | 2023 | 404 | 2.100 |
Why?
|
| Genetic Loci | 30 | 2023 | 2614 | 2.050 |
Why?
|
| Risk Factors | 214 | 2024 | 73094 | 1.960 |
Why?
|
| Sleep Apnea, Central | 7 | 2017 | 84 | 1.930 |
Why?
|
| Middle Aged | 351 | 2024 | 216054 | 1.910 |
Why?
|
| Polymorphism, Single Nucleotide | 91 | 2024 | 15657 | 1.740 |
Why?
|
| Cohort Studies | 165 | 2024 | 40939 | 1.700 |
Why?
|
| Asthma | 33 | 2024 | 6089 | 1.540 |
Why?
|
| Prevalence | 76 | 2023 | 15404 | 1.390 |
Why?
|
| Aged, 80 and over | 150 | 2023 | 58361 | 1.360 |
Why?
|
| Oxyhemoglobins | 10 | 2023 | 215 | 1.320 |
Why?
|
| C-Reactive Protein | 14 | 2024 | 3814 | 1.320 |
Why?
|
| Cardiovascular System | 7 | 2023 | 834 | 1.290 |
Why?
|
| Sex Factors | 41 | 2021 | 10469 | 1.270 |
Why?
|
| Prospective Studies | 122 | 2024 | 53863 | 1.250 |
Why?
|
| Electroencephalography | 24 | 2023 | 6117 | 1.250 |
Why?
|
| Adult | 241 | 2024 | 216658 | 1.230 |
Why?
|
| Blood Glucose | 21 | 2022 | 6318 | 1.220 |
Why?
|
| Restless Legs Syndrome | 7 | 2023 | 228 | 1.200 |
Why?
|
| Genetic Predisposition to Disease | 58 | 2024 | 17635 | 1.200 |
Why?
|
| Nocturnal Myoclonus Syndrome | 11 | 2018 | 50 | 1.200 |
Why?
|
| Severity of Illness Index | 65 | 2024 | 15657 | 1.170 |
Why?
|
| Lipids | 15 | 2023 | 3326 | 1.160 |
Why?
|
| Residence Characteristics | 19 | 2022 | 2064 | 1.140 |
Why?
|
| Rest | 10 | 2023 | 915 | 1.130 |
Why?
|
| Biomedical Research | 13 | 2021 | 3349 | 1.130 |
Why?
|
| Health Status | 24 | 2022 | 4077 | 1.110 |
Why?
|
| Child | 117 | 2024 | 78594 | 1.070 |
Why?
|
| Glucose Metabolism Disorders | 4 | 2020 | 54 | 1.050 |
Why?
|
| Exercise | 14 | 2022 | 5662 | 1.050 |
Why?
|
| Watchful Waiting | 6 | 2023 | 499 | 1.050 |
Why?
|
| Coronary Artery Disease | 17 | 2024 | 6565 | 1.040 |
Why?
|
| Arousal | 18 | 2023 | 1164 | 1.040 |
Why?
|
| Ohio | 19 | 2016 | 336 | 1.030 |
Why?
|
| Longitudinal Studies | 54 | 2022 | 14219 | 1.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 31 | 2024 | 11909 | 1.010 |
Why?
|
| Electrocardiography | 25 | 2022 | 6458 | 1.000 |
Why?
|
| Adiposity | 13 | 2022 | 1823 | 0.990 |
Why?
|
| United States | 130 | 2024 | 70772 | 0.990 |
Why?
|
| Carotid Artery Diseases | 2 | 2022 | 890 | 0.980 |
Why?
|
| Quality of Life | 30 | 2024 | 13044 | 0.970 |
Why?
|
| Phenotype | 59 | 2024 | 16484 | 0.970 |
Why?
|
| Respiratory System Abnormalities | 2 | 2019 | 69 | 0.970 |
Why?
|
| Minority Groups | 8 | 2023 | 1227 | 0.950 |
Why?
|
| Adolescent | 111 | 2024 | 86713 | 0.940 |
Why?
|
| Genome, Human | 18 | 2023 | 4446 | 0.930 |
Why?
|
| Quantitative Trait Loci | 13 | 2023 | 2049 | 0.920 |
Why?
|
| Health Surveys | 21 | 2018 | 4050 | 0.920 |
Why?
|
| Heart Rate | 22 | 2024 | 4108 | 0.920 |
Why?
|
| Glucose Intolerance | 6 | 2013 | 576 | 0.920 |
Why?
|
| Body Height | 9 | 2022 | 1586 | 0.900 |
Why?
|
| Cognition Disorders | 18 | 2018 | 4042 | 0.890 |
Why?
|
| Time Factors | 70 | 2023 | 40195 | 0.870 |
Why?
|
| Health Status Disparities | 9 | 2019 | 1812 | 0.870 |
Why?
|
| Oxygen Inhalation Therapy | 3 | 2017 | 370 | 0.860 |
Why?
|
| Multifactorial Inheritance | 14 | 2024 | 1258 | 0.840 |
Why?
|
| Child Behavior | 5 | 2017 | 836 | 0.830 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 10 | 2022 | 314 | 0.830 |
Why?
|
| Cognition | 21 | 2023 | 6844 | 0.830 |
Why?
|
| Child, Preschool | 68 | 2024 | 41390 | 0.830 |
Why?
|
| Odds Ratio | 45 | 2022 | 9863 | 0.820 |
Why?
|
| Arrhythmias, Cardiac | 8 | 2014 | 2264 | 0.820 |
Why?
|
| Atrial Fibrillation | 15 | 2022 | 5064 | 0.810 |
Why?
|
| Independent Living | 12 | 2022 | 580 | 0.800 |
Why?
|
| Wakefulness | 14 | 2022 | 1246 | 0.790 |
Why?
|
| Beginning of Human Life | 1 | 2021 | 11 | 0.780 |
Why?
|
| Social Class | 8 | 2017 | 2005 | 0.780 |
Why?
|
| Poverty | 7 | 2020 | 2682 | 0.780 |
Why?
|
| Comorbidity | 42 | 2021 | 10450 | 0.760 |
Why?
|
| Blood Circulation Time | 1 | 2020 | 11 | 0.760 |
Why?
|
| Incidence | 41 | 2024 | 21146 | 0.750 |
Why?
|
| Yoga | 3 | 2020 | 254 | 0.740 |
Why?
|
| Age Factors | 45 | 2021 | 18460 | 0.740 |
Why?
|
| Patient Compliance | 10 | 2020 | 2708 | 0.730 |
Why?
|
| Insulin Resistance | 11 | 2022 | 3889 | 0.730 |
Why?
|
| Diabetes Mellitus | 12 | 2024 | 5799 | 0.730 |
Why?
|
| Signal Processing, Computer-Assisted | 7 | 2017 | 1521 | 0.730 |
Why?
|
| Genetic Variation | 19 | 2022 | 6567 | 0.720 |
Why?
|
| Sleep Arousal Disorders | 1 | 2019 | 11 | 0.700 |
Why?
|
| Technology | 2 | 2022 | 307 | 0.690 |
Why?
|
| Interleukin-18 Receptor alpha Subunit | 1 | 2019 | 18 | 0.690 |
Why?
|
| Follow-Up Studies | 48 | 2024 | 39223 | 0.690 |
Why?
|
| Movement | 6 | 2023 | 1478 | 0.680 |
Why?
|
| Pharynx | 5 | 2022 | 423 | 0.680 |
Why?
|
| Work | 2 | 2019 | 194 | 0.670 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2015 | 717 | 0.660 |
Why?
|
| Genetic Linkage | 11 | 2022 | 2409 | 0.660 |
Why?
|
| Parenting | 6 | 2022 | 695 | 0.650 |
Why?
|
| Hexokinase | 1 | 2019 | 126 | 0.650 |
Why?
|
| Respiration | 17 | 2021 | 1674 | 0.650 |
Why?
|
| Linear Models | 25 | 2020 | 5965 | 0.650 |
Why?
|
| Overweight | 7 | 2020 | 2393 | 0.650 |
Why?
|
| Genotype | 39 | 2021 | 12970 | 0.640 |
Why?
|
| Pulmonary Medicine | 5 | 2019 | 217 | 0.640 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2022 | 2191 | 0.640 |
Why?
|
| Risk Assessment | 27 | 2023 | 23554 | 0.630 |
Why?
|
| Genetics, Population | 10 | 2021 | 938 | 0.620 |
Why?
|
| Caffeine | 2 | 2019 | 703 | 0.620 |
Why?
|
| Lung | 22 | 2023 | 9990 | 0.620 |
Why?
|
| Waist Circumference | 8 | 2019 | 924 | 0.610 |
Why?
|
| Ventricular Function, Left | 4 | 2020 | 3715 | 0.610 |
Why?
|
| Lung Diseases, Interstitial | 3 | 2023 | 836 | 0.600 |
Why?
|
| Life Style | 11 | 2023 | 3861 | 0.600 |
Why?
|
| Single-Parent Family | 1 | 2017 | 6 | 0.590 |
Why?
|
| Coronary Disease | 10 | 2019 | 6083 | 0.590 |
Why?
|
| Interleukin-6 | 7 | 2022 | 3198 | 0.590 |
Why?
|
| Pregnancy Complications | 9 | 2023 | 2899 | 0.590 |
Why?
|
| Genetic Association Studies | 17 | 2022 | 2711 | 0.590 |
Why?
|
| Oxygen | 23 | 2024 | 4208 | 0.590 |
Why?
|
| Young Adult | 63 | 2024 | 57267 | 0.580 |
Why?
|
| Randomized Controlled Trials as Topic | 13 | 2022 | 10057 | 0.580 |
Why?
|
| Body Weight | 12 | 2022 | 4703 | 0.580 |
Why?
|
| Neuropsychological Tests | 24 | 2023 | 7008 | 0.570 |
Why?
|
| Cephalometry | 7 | 2007 | 383 | 0.570 |
Why?
|
| Vitamin D | 6 | 2020 | 3259 | 0.570 |
Why?
|
| Long QT Syndrome | 4 | 2022 | 454 | 0.570 |
Why?
|
| Aging | 22 | 2023 | 8752 | 0.570 |
Why?
|
| Oximetry | 10 | 2020 | 471 | 0.570 |
Why?
|
| Logistic Models | 35 | 2019 | 13441 | 0.560 |
Why?
|
| Allostasis | 2 | 2024 | 71 | 0.560 |
Why?
|
| Weather | 1 | 2017 | 228 | 0.550 |
Why?
|
| Heart Ventricles | 4 | 2022 | 3845 | 0.550 |
Why?
|
| Respiratory Sounds | 2 | 2014 | 696 | 0.550 |
Why?
|
| Cholesterol, HDL | 14 | 2020 | 1817 | 0.540 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 12 | 2022 | 3077 | 0.540 |
Why?
|
| Infant, Premature | 7 | 2014 | 2060 | 0.540 |
Why?
|
| Mississippi | 3 | 2020 | 89 | 0.530 |
Why?
|
| Schools | 8 | 2021 | 1443 | 0.530 |
Why?
|
| Light | 2 | 2019 | 1332 | 0.530 |
Why?
|
| Semantics | 2 | 2018 | 593 | 0.530 |
Why?
|
| Models, Genetic | 12 | 2024 | 3489 | 0.530 |
Why?
|
| Anemia, Sickle Cell | 8 | 2019 | 1029 | 0.520 |
Why?
|
| Chromosome Mapping | 10 | 2022 | 4723 | 0.520 |
Why?
|
| Anthropometry | 10 | 2022 | 1357 | 0.520 |
Why?
|
| Inflammation | 13 | 2023 | 10751 | 0.510 |
Why?
|
| Hyperglycemia | 2 | 2022 | 1380 | 0.510 |
Why?
|
| Heart Failure | 13 | 2021 | 11096 | 0.510 |
Why?
|
| Research Design | 14 | 2024 | 6118 | 0.510 |
Why?
|
| Metabolic Diseases | 2 | 2019 | 671 | 0.510 |
Why?
|
| Reproducibility of Results | 29 | 2023 | 20026 | 0.500 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2020 | 281 | 0.500 |
Why?
|
| Stress, Psychological | 9 | 2019 | 4316 | 0.500 |
Why?
|
| Fibrinogen | 5 | 2019 | 893 | 0.500 |
Why?
|
| Seasons | 3 | 2017 | 1511 | 0.500 |
Why?
|
| Placebos | 1 | 2019 | 1675 | 0.500 |
Why?
|
| Depression | 19 | 2024 | 7876 | 0.500 |
Why?
|
| Alcohol Drinking | 4 | 2022 | 3998 | 0.490 |
Why?
|
| Cheyne-Stokes Respiration | 4 | 2017 | 38 | 0.490 |
Why?
|
| Pulmonary Ventilation | 4 | 2010 | 374 | 0.490 |
Why?
|
| Nicotine | 1 | 2019 | 686 | 0.490 |
Why?
|
| Dementia | 10 | 2023 | 2590 | 0.480 |
Why?
|
| Meditation | 1 | 2017 | 243 | 0.480 |
Why?
|
| Leukocyte Count | 1 | 2018 | 1604 | 0.480 |
Why?
|
| Apolipoproteins E | 6 | 2021 | 1445 | 0.480 |
Why?
|
| Health Behavior | 4 | 2017 | 2648 | 0.480 |
Why?
|
| Fasting | 11 | 2022 | 1607 | 0.470 |
Why?
|
| Monitoring, Ambulatory | 2 | 2017 | 357 | 0.470 |
Why?
|
| Students | 6 | 2021 | 1668 | 0.460 |
Why?
|
| Hygiene | 1 | 2013 | 97 | 0.440 |
Why?
|
| Carbon Dioxide | 2 | 2015 | 1162 | 0.440 |
Why?
|
| Melatonin | 4 | 2024 | 661 | 0.430 |
Why?
|
| Dyslipidemias | 2 | 2018 | 865 | 0.430 |
Why?
|
| Mexican Americans | 3 | 2016 | 163 | 0.430 |
Why?
|
| Stroke | 14 | 2024 | 10152 | 0.430 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 3 | 2013 | 195 | 0.430 |
Why?
|
| Eating | 2 | 2018 | 1563 | 0.420 |
Why?
|
| Sex Characteristics | 9 | 2022 | 2610 | 0.420 |
Why?
|
| Algorithms | 13 | 2023 | 13984 | 0.410 |
Why?
|
| Phylogeny | 1 | 2019 | 2820 | 0.410 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 2 | 2014 | 425 | 0.410 |
Why?
|
| Plethysmography, Impedance | 1 | 2011 | 43 | 0.410 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 5 | 2022 | 249 | 0.410 |
Why?
|
| Myocardial Infarction | 8 | 2023 | 11824 | 0.410 |
Why?
|
| Mortality | 9 | 2020 | 2899 | 0.410 |
Why?
|
| Multivariate Analysis | 24 | 2019 | 12250 | 0.400 |
Why?
|
| Linkage Disequilibrium | 11 | 2022 | 1999 | 0.400 |
Why?
|
| Apolipoprotein E4 | 6 | 2023 | 677 | 0.400 |
Why?
|
| Albuminuria | 3 | 2017 | 670 | 0.400 |
Why?
|
| Diastole | 8 | 2020 | 792 | 0.400 |
Why?
|
| Autonomic Nervous System | 5 | 2022 | 673 | 0.400 |
Why?
|
| Single-Blind Method | 5 | 2024 | 1593 | 0.390 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2014 | 821 | 0.390 |
Why?
|
| Cooperative Behavior | 4 | 2017 | 1508 | 0.390 |
Why?
|
| Air Pollution | 4 | 2022 | 2326 | 0.390 |
Why?
|
| Peripheral Arterial Disease | 4 | 2024 | 1221 | 0.390 |
Why?
|
| Alzheimer Disease | 7 | 2024 | 8199 | 0.380 |
Why?
|
| Mosaicism | 2 | 2024 | 442 | 0.380 |
Why?
|
| Angiopoietin-2 | 3 | 2024 | 177 | 0.380 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2022 | 1529 | 0.380 |
Why?
|
| Caregivers | 9 | 2023 | 2149 | 0.370 |
Why?
|
| Triglycerides | 9 | 2020 | 2465 | 0.370 |
Why?
|
| Polyvinyls | 1 | 2011 | 157 | 0.370 |
Why?
|
| Adolescent Behavior | 2 | 2011 | 1162 | 0.370 |
Why?
|
| Predictive Value of Tests | 19 | 2022 | 15164 | 0.370 |
Why?
|
| Dietary Supplements | 3 | 2024 | 3344 | 0.370 |
Why?
|
| Patient Selection | 5 | 2021 | 4232 | 0.370 |
Why?
|
| Postmenopause | 7 | 2019 | 2478 | 0.360 |
Why?
|
| Hypertrophy, Left Ventricular | 4 | 2020 | 854 | 0.360 |
Why?
|
| Emigrants and Immigrants | 3 | 2024 | 527 | 0.360 |
Why?
|
| Periodontitis | 1 | 2015 | 558 | 0.360 |
Why?
|
| Gravitation | 1 | 2010 | 83 | 0.360 |
Why?
|
| Extremities | 2 | 2018 | 872 | 0.360 |
Why?
|
| Biological Specimen Banks | 4 | 2023 | 726 | 0.360 |
Why?
|
| Alleles | 16 | 2023 | 6954 | 0.360 |
Why?
|
| Information Dissemination | 1 | 2018 | 1107 | 0.360 |
Why?
|
| Focus Groups | 5 | 2023 | 1348 | 0.360 |
Why?
|
| Interprofessional Relations | 1 | 2016 | 1019 | 0.350 |
Why?
|
| Smoking | 17 | 2022 | 9030 | 0.350 |
Why?
|
| Receptors, Interleukin-6 | 2 | 2012 | 227 | 0.340 |
Why?
|
| Calcinosis | 2 | 2015 | 1499 | 0.340 |
Why?
|
| Systole | 6 | 2020 | 960 | 0.340 |
Why?
|
| Geriatric Assessment | 8 | 2014 | 1390 | 0.340 |
Why?
|
| Leptin | 3 | 2014 | 1621 | 0.340 |
Why?
|
| Respiratory Rate | 2 | 2021 | 168 | 0.330 |
Why?
|
| Face | 4 | 2007 | 1008 | 0.330 |
Why?
|
| Socioeconomic Factors | 15 | 2021 | 7852 | 0.330 |
Why?
|
| Particulate Matter | 2 | 2019 | 2574 | 0.330 |
Why?
|
| Job Satisfaction | 1 | 2013 | 538 | 0.330 |
Why?
|
| Gene Frequency | 16 | 2022 | 3591 | 0.330 |
Why?
|
| Habits | 2 | 2009 | 140 | 0.330 |
Why?
|
| Sex Distribution | 9 | 2011 | 2304 | 0.330 |
Why?
|
| Cluster Analysis | 4 | 2023 | 2719 | 0.330 |
Why?
|
| Heterozygote | 6 | 2022 | 2816 | 0.330 |
Why?
|
| Walking | 1 | 2016 | 1192 | 0.330 |
Why?
|
| Neutrophils | 2 | 2018 | 3729 | 0.330 |
Why?
|
| Insulin | 11 | 2022 | 6623 | 0.330 |
Why?
|
| Public Health | 6 | 2023 | 2634 | 0.330 |
Why?
|
| Proportional Hazards Models | 18 | 2023 | 12423 | 0.320 |
Why?
|
| Poverty Areas | 3 | 2006 | 274 | 0.320 |
Why?
|
| Research | 4 | 2021 | 2001 | 0.320 |
Why?
|
| Psychometrics | 5 | 2023 | 3014 | 0.320 |
Why?
|
| Statistics as Topic | 14 | 2016 | 2376 | 0.320 |
Why?
|
| Weight Gain | 4 | 2022 | 2317 | 0.320 |
Why?
|
| Pregnancy Outcome | 6 | 2023 | 2854 | 0.310 |
Why?
|
| Executive Function | 3 | 2023 | 1375 | 0.310 |
Why?
|
| Infant | 25 | 2024 | 35447 | 0.300 |
Why?
|
| Epistasis, Genetic | 3 | 2020 | 364 | 0.300 |
Why?
|
| Heart Diseases | 3 | 2015 | 2802 | 0.300 |
Why?
|
| Forced Expiratory Volume | 12 | 2019 | 1748 | 0.300 |
Why?
|
| Occupations | 3 | 2014 | 515 | 0.300 |
Why?
|
| Case-Control Studies | 27 | 2021 | 21904 | 0.300 |
Why?
|
| Narcolepsy | 2 | 2022 | 196 | 0.290 |
Why?
|
| Factor Analysis, Statistical | 6 | 2021 | 985 | 0.290 |
Why?
|
| Feeding Behavior | 4 | 2022 | 3204 | 0.290 |
Why?
|
| Neck | 4 | 2021 | 713 | 0.280 |
Why?
|
| Cholesterol, LDL | 11 | 2022 | 2385 | 0.280 |
Why?
|
| Patient-Centered Care | 2 | 2016 | 1445 | 0.280 |
Why?
|
| Social Adjustment | 1 | 2009 | 633 | 0.280 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2021 | 544 | 0.280 |
Why?
|
| Obesity, Abdominal | 4 | 2023 | 362 | 0.280 |
Why?
|
| Pre-Eclampsia | 5 | 2023 | 1236 | 0.280 |
Why?
|
| Career Choice | 1 | 2013 | 751 | 0.280 |
Why?
|
| Underachievement | 1 | 2006 | 15 | 0.280 |
Why?
|
| Comparative Effectiveness Research | 1 | 2012 | 693 | 0.280 |
Why?
|
| Parents | 7 | 2022 | 3448 | 0.280 |
Why?
|
| Positive-Pressure Respiration | 8 | 2020 | 637 | 0.270 |
Why?
|
| Aircraft | 2 | 2024 | 128 | 0.270 |
Why?
|
| Spirometry | 10 | 2021 | 871 | 0.270 |
Why?
|
| Noise, Transportation | 2 | 2024 | 53 | 0.270 |
Why?
|
| Multicenter Studies as Topic | 5 | 2022 | 1690 | 0.270 |
Why?
|
| Patients | 1 | 2013 | 904 | 0.270 |
Why?
|
| Morbidity | 5 | 2022 | 1784 | 0.270 |
Why?
|
| Patient Satisfaction | 2 | 2018 | 3433 | 0.270 |
Why?
|
| Qualitative Research | 4 | 2020 | 2778 | 0.270 |
Why?
|
| Inpatients | 2 | 2023 | 2549 | 0.270 |
Why?
|
| Regression Analysis | 13 | 2024 | 6458 | 0.270 |
Why?
|
| Urban Population | 9 | 2017 | 2031 | 0.270 |
Why?
|
| Telomere | 2 | 2024 | 924 | 0.260 |
Why?
|
| Germ-Line Mutation | 3 | 2023 | 1814 | 0.260 |
Why?
|
| Age Distribution | 9 | 2014 | 2905 | 0.260 |
Why?
|
| Cerebrovascular Circulation | 3 | 2019 | 2748 | 0.260 |
Why?
|
| Respiratory Function Tests | 7 | 2021 | 1631 | 0.260 |
Why?
|
| Peak Expiratory Flow Rate | 5 | 2006 | 142 | 0.260 |
Why?
|
| Hypersensitivity | 2 | 2004 | 1123 | 0.260 |
Why?
|
| Respiratory Therapy | 2 | 2014 | 133 | 0.260 |
Why?
|
| Dietary Carbohydrates | 1 | 2010 | 904 | 0.260 |
Why?
|
| Nerve Tissue Proteins | 9 | 2022 | 4455 | 0.260 |
Why?
|
| Mendelian Randomization Analysis | 6 | 2023 | 999 | 0.260 |
Why?
|
| Hip Fractures | 3 | 2022 | 975 | 0.260 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2007 | 365 | 0.250 |
Why?
|
| Treatment Outcome | 26 | 2023 | 64017 | 0.250 |
Why?
|
| Activities of Daily Living | 7 | 2017 | 2457 | 0.250 |
Why?
|
| Waist-Hip Ratio | 6 | 2023 | 517 | 0.250 |
Why?
|
| Energy Intake | 3 | 2015 | 2165 | 0.250 |
Why?
|
| Meta-Analysis as Topic | 7 | 2020 | 1364 | 0.250 |
Why?
|
| School Nursing | 1 | 2004 | 32 | 0.250 |
Why?
|
| Pedigree | 8 | 2020 | 4637 | 0.250 |
Why?
|
| Health Occupations | 2 | 2018 | 224 | 0.240 |
Why?
|
| Pituitary-Adrenal System | 3 | 2017 | 552 | 0.240 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 2020 | 191 | 0.240 |
Why?
|
| Hypertension, Pregnancy-Induced | 3 | 2020 | 500 | 0.240 |
Why?
|
| Spinal Fractures | 2 | 2022 | 695 | 0.240 |
Why?
|
| Research Report | 2 | 2020 | 354 | 0.240 |
Why?
|
| Databases, Factual | 2 | 2018 | 7805 | 0.240 |
Why?
|
| Diabetes, Gestational | 3 | 2023 | 1202 | 0.240 |
Why?
|
| Infant, Small for Gestational Age | 3 | 2021 | 448 | 0.240 |
Why?
|
| Pregnancy | 22 | 2024 | 29630 | 0.240 |
Why?
|
| Airports | 1 | 2024 | 31 | 0.240 |
Why?
|
| Social Environment | 4 | 2021 | 1025 | 0.240 |
Why?
|
| Demography | 4 | 2018 | 1661 | 0.230 |
Why?
|
| Neoplasms | 4 | 2021 | 21976 | 0.230 |
Why?
|
| Child Behavior Disorders | 2 | 2009 | 805 | 0.230 |
Why?
|
| Informatics | 2 | 2022 | 73 | 0.230 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2017 | 703 | 0.230 |
Why?
|
| Urban Health | 2 | 2010 | 547 | 0.230 |
Why?
|
| Infant, Newborn | 17 | 2023 | 25903 | 0.230 |
Why?
|
| Vital Capacity | 7 | 2022 | 932 | 0.230 |
Why?
|
| Glucose Tolerance Test | 6 | 2015 | 1168 | 0.230 |
Why?
|
| Airway Obstruction | 2 | 2022 | 660 | 0.230 |
Why?
|
| Photography | 1 | 2007 | 523 | 0.230 |
Why?
|
| Prognosis | 20 | 2021 | 29264 | 0.230 |
Why?
|
| Artificial Intelligence | 3 | 2023 | 2313 | 0.220 |
Why?
|
| Antihypertensive Agents | 6 | 2022 | 2083 | 0.220 |
Why?
|
| Papaver | 1 | 2022 | 3 | 0.220 |
Why?
|
| Hydrocortisone | 3 | 2017 | 1824 | 0.220 |
Why?
|
| Palatal Expansion Technique | 1 | 2023 | 26 | 0.220 |
Why?
|
| Home Care Services | 4 | 2015 | 622 | 0.220 |
Why?
|
| Electrooculography | 6 | 2007 | 116 | 0.220 |
Why?
|
| Family | 7 | 2021 | 3175 | 0.220 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2003 | 59 | 0.220 |
Why?
|
| Genome | 2 | 2022 | 1806 | 0.220 |
Why?
|
| Diet | 7 | 2022 | 7969 | 0.220 |
Why?
|
| Polymorphism, Genetic | 2 | 2019 | 4327 | 0.220 |
Why?
|
| Disease Susceptibility | 5 | 2022 | 1779 | 0.220 |
Why?
|
| Ventricular Remodeling | 3 | 2020 | 1229 | 0.220 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2004 | 304 | 0.220 |
Why?
|
| Models, Statistical | 6 | 2020 | 5107 | 0.220 |
Why?
|
| Depressive Disorder | 4 | 2019 | 3759 | 0.220 |
Why?
|
| Sensitivity and Specificity | 12 | 2017 | 14761 | 0.210 |
Why?
|
| Tumor Necrosis Factors | 1 | 2022 | 110 | 0.210 |
Why?
|
| Posture | 3 | 2019 | 962 | 0.210 |
Why?
|
| Biometry | 2 | 2004 | 564 | 0.210 |
Why?
|
| Dioxins | 1 | 2023 | 103 | 0.210 |
Why?
|
| Disabled Children | 2 | 2015 | 250 | 0.210 |
Why?
|
| Gestational Age | 7 | 2023 | 3555 | 0.210 |
Why?
|
| Dietary Fats | 1 | 2010 | 2012 | 0.210 |
Why?
|
| Fathers | 2 | 2021 | 359 | 0.210 |
Why?
|
| Tachycardia, Ventricular | 2 | 2022 | 1286 | 0.210 |
Why?
|
| Troponin T | 4 | 2015 | 766 | 0.210 |
Why?
|
| Infant, Premature, Diseases | 1 | 2008 | 704 | 0.210 |
Why?
|
| Transcription Factors | 4 | 2019 | 12165 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2019 | 457 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2024 | 3512 | 0.200 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2003 | 131 | 0.200 |
Why?
|
| Mass Screening | 4 | 2021 | 5282 | 0.200 |
Why?
|
| Analysis of Variance | 9 | 2015 | 6352 | 0.200 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2022 | 199 | 0.200 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2014 | 3966 | 0.200 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2021 | 1556 | 0.200 |
Why?
|
| Osteoporosis | 5 | 2015 | 1582 | 0.200 |
Why?
|
| Telemedicine | 1 | 2019 | 2990 | 0.200 |
Why?
|
| Microvessels | 2 | 2016 | 565 | 0.190 |
Why?
|
| Pregnancy Trimesters | 2 | 2019 | 193 | 0.190 |
Why?
|
| Coronary Vessels | 3 | 2022 | 3147 | 0.190 |
Why?
|
| Clinical Trials as Topic | 5 | 2023 | 7970 | 0.190 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 1901 | 0.190 |
Why?
|
| Reference Values | 5 | 2020 | 4994 | 0.190 |
Why?
|
| Electronic Health Records | 4 | 2023 | 4579 | 0.190 |
Why?
|
| Motor Activity | 5 | 2017 | 2715 | 0.190 |
Why?
|
| Causality | 8 | 2023 | 1285 | 0.190 |
Why?
|
| Benchmarking | 3 | 2023 | 1048 | 0.190 |
Why?
|
| Community Health Services | 4 | 2020 | 653 | 0.190 |
Why?
|
| Health Services Needs and Demand | 2 | 2021 | 1417 | 0.190 |
Why?
|
| Endophenotypes | 1 | 2022 | 250 | 0.190 |
Why?
|
| Jet Lag Syndrome | 1 | 2020 | 25 | 0.180 |
Why?
|
| Sinoatrial Node | 1 | 2020 | 100 | 0.180 |
Why?
|
| Endothelium, Vascular | 5 | 2013 | 4459 | 0.180 |
Why?
|
| Oxidants, Photochemical | 1 | 2000 | 78 | 0.180 |
Why?
|
| Mandibular Advancement | 1 | 2020 | 63 | 0.180 |
Why?
|
| Computational Biology | 5 | 2021 | 3531 | 0.180 |
Why?
|
| Accidental Falls | 3 | 2014 | 1066 | 0.180 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2022 | 3605 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2019 | 349 | 0.180 |
Why?
|
| Retinal Vessels | 2 | 2016 | 790 | 0.180 |
Why?
|
| Heme | 1 | 2022 | 305 | 0.180 |
Why?
|
| Genomics | 5 | 2022 | 5743 | 0.180 |
Why?
|
| Acoustics | 3 | 2008 | 244 | 0.180 |
Why?
|
| Albumins | 1 | 2022 | 564 | 0.180 |
Why?
|
| Mental Processes | 1 | 2001 | 246 | 0.180 |
Why?
|
| Postoperative Period | 2 | 2015 | 1848 | 0.180 |
Why?
|
| Brain | 11 | 2024 | 26598 | 0.180 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 2020 | 1593 | 0.170 |
Why?
|
| Blood Circulation | 1 | 2020 | 251 | 0.170 |
Why?
|
| Cerebrovascular Disorders | 4 | 2016 | 1514 | 0.170 |
Why?
|
| Antigens, CD1d | 1 | 2020 | 220 | 0.170 |
Why?
|
| Perceptual Disorders | 1 | 2001 | 193 | 0.170 |
Why?
|
| Chromosomes, Human, X | 1 | 2021 | 296 | 0.170 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2021 | 235 | 0.170 |
Why?
|
| Interdisciplinary Communication | 2 | 2017 | 948 | 0.170 |
Why?
|
| Tomography | 1 | 2021 | 398 | 0.170 |
Why?
|
| Environment | 1 | 2005 | 1123 | 0.170 |
Why?
|
| Sample Size | 5 | 2022 | 841 | 0.170 |
Why?
|
| Ferrochelatase | 1 | 2019 | 46 | 0.170 |
Why?
|
| Genetic Fitness | 1 | 2020 | 125 | 0.170 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2022 | 780 | 0.170 |
Why?
|
| Evidence-Based Medicine | 3 | 2017 | 3652 | 0.170 |
Why?
|
| Weight Loss | 7 | 2024 | 2679 | 0.170 |
Why?
|
| Basal Metabolism | 1 | 2020 | 167 | 0.160 |
Why?
|
| Skull | 3 | 2001 | 830 | 0.160 |
Why?
|
| Femur Neck | 1 | 2020 | 309 | 0.160 |
Why?
|
| Sudden Infant Death | 2 | 1999 | 296 | 0.160 |
Why?
|
| Psychotherapy, Group | 1 | 2022 | 413 | 0.160 |
Why?
|
| Brain Stem | 1 | 2004 | 863 | 0.160 |
Why?
|
| Canada | 2 | 2022 | 2081 | 0.160 |
Why?
|
| Self Care | 3 | 2016 | 787 | 0.160 |
Why?
|
| Phosphatidylethanolamine N-Methyltransferase | 1 | 2018 | 20 | 0.160 |
Why?
|
| Internet | 4 | 2022 | 3074 | 0.160 |
Why?
|
| Chi-Square Distribution | 9 | 2015 | 3500 | 0.160 |
Why?
|
| Cardiac Electrophysiology | 1 | 2018 | 50 | 0.160 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2020 | 248 | 0.160 |
Why?
|
| Retrospective Studies | 16 | 2021 | 78758 | 0.160 |
Why?
|
| Open Reading Frames | 1 | 2021 | 811 | 0.160 |
Why?
|
| Pulmonary Circulation | 1 | 2021 | 750 | 0.160 |
Why?
|
| Basilar Artery | 2 | 2019 | 205 | 0.160 |
Why?
|
| Adaptation, Psychological | 1 | 2009 | 2611 | 0.160 |
Why?
|
| Body Size | 1 | 2021 | 461 | 0.160 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2018 | 786 | 0.160 |
Why?
|
| Pharyngeal Diseases | 1 | 2019 | 135 | 0.160 |
Why?
|
| Thorax | 2 | 2020 | 550 | 0.160 |
Why?
|
| Horses | 1 | 2019 | 305 | 0.160 |
Why?
|
| Feasibility Studies | 8 | 2020 | 5144 | 0.160 |
Why?
|
| Intention to Treat Analysis | 2 | 2016 | 423 | 0.160 |
Why?
|
| Employment | 3 | 2022 | 1140 | 0.160 |
Why?
|
| Fractures, Spontaneous | 3 | 2010 | 232 | 0.160 |
Why?
|
| Anxiety | 3 | 2020 | 4395 | 0.150 |
Why?
|
| Transportation | 1 | 2019 | 215 | 0.150 |
Why?
|
| Bronchi | 4 | 1989 | 851 | 0.150 |
Why?
|
| Knowledge Bases | 1 | 2018 | 89 | 0.150 |
Why?
|
| Space Perception | 1 | 2001 | 478 | 0.150 |
Why?
|
| Leisure Activities | 1 | 2019 | 311 | 0.150 |
Why?
|
| Inspiratory Capacity | 1 | 2017 | 36 | 0.150 |
Why?
|
| Disease Progression | 9 | 2024 | 13364 | 0.150 |
Why?
|
| Nocturia | 1 | 2017 | 19 | 0.150 |
Why?
|
| Anxiety Disorders | 1 | 2009 | 2713 | 0.150 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2018 | 137 | 0.150 |
Why?
|
| Europe | 6 | 2022 | 3359 | 0.150 |
Why?
|
| Policy Making | 1 | 2021 | 552 | 0.150 |
Why?
|
| Atrial Premature Complexes | 1 | 2017 | 17 | 0.150 |
Why?
|
| Electromyography | 7 | 2011 | 1390 | 0.150 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2019 | 266 | 0.150 |
Why?
|
| American Heart Association | 3 | 2024 | 1065 | 0.150 |
Why?
|
| Chromosome Aberrations | 1 | 2024 | 1806 | 0.150 |
Why?
|
| Twins, Dizygotic | 2 | 1989 | 235 | 0.150 |
Why?
|
| Amino Acids | 1 | 2023 | 1744 | 0.150 |
Why?
|
| Absorptiometry, Photon | 3 | 2019 | 1748 | 0.150 |
Why?
|
| Middle Cerebral Artery | 1 | 2019 | 271 | 0.150 |
Why?
|
| Attention | 3 | 2023 | 2398 | 0.150 |
Why?
|
| Ozone | 1 | 2000 | 472 | 0.150 |
Why?
|
| Premature Birth | 2 | 2023 | 1764 | 0.150 |
Why?
|
| Fingers | 1 | 2020 | 513 | 0.150 |
Why?
|
| Ventricular Function, Right | 1 | 2021 | 602 | 0.150 |
Why?
|
| Sodium | 1 | 2022 | 1625 | 0.150 |
Why?
|
| Carbamates | 1 | 2018 | 201 | 0.150 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2019 | 296 | 0.150 |
Why?
|
| Cross-Over Studies | 3 | 2012 | 2043 | 0.150 |
Why?
|
| Internationality | 1 | 2022 | 999 | 0.140 |
Why?
|
| Haplotypes | 6 | 2022 | 2776 | 0.140 |
Why?
|
| Galectin 3 | 1 | 2019 | 242 | 0.140 |
Why?
|
| Health Care Costs | 4 | 2020 | 3217 | 0.140 |
Why?
|
| Hematopoiesis | 2 | 2023 | 2087 | 0.140 |
Why?
|
| Sampling Studies | 4 | 2004 | 623 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2020 | 2088 | 0.140 |
Why?
|
| Nurses | 2 | 2024 | 2476 | 0.140 |
Why?
|
| Football | 1 | 2022 | 465 | 0.140 |
Why?
|
| Systems Integration | 1 | 2018 | 441 | 0.140 |
Why?
|
| Hemoglobins | 1 | 2022 | 1537 | 0.140 |
Why?
|
| Radial Artery | 1 | 2018 | 195 | 0.140 |
Why?
|
| Principal Component Analysis | 2 | 2017 | 942 | 0.140 |
Why?
|
| Atrial Function, Left | 1 | 2017 | 178 | 0.140 |
Why?
|
| Twins | 2 | 1989 | 339 | 0.140 |
Why?
|
| Dehydroepiandrosterone | 1 | 2017 | 254 | 0.140 |
Why?
|
| Wrist | 2 | 2008 | 225 | 0.140 |
Why?
|
| Guidelines as Topic | 2 | 2020 | 1402 | 0.140 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 496 | 0.140 |
Why?
|
| Biological Clocks | 1 | 2018 | 319 | 0.140 |
Why?
|
| Twins, Monozygotic | 2 | 1989 | 463 | 0.140 |
Why?
|
| Hospitalization | 9 | 2020 | 10422 | 0.140 |
Why?
|
| Breast Feeding | 2 | 2022 | 1335 | 0.140 |
Why?
|
| Family Health | 4 | 2017 | 1279 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2024 | 3404 | 0.140 |
Why?
|
| Cause of Death | 5 | 2019 | 3628 | 0.140 |
Why?
|
| Thrombosis | 1 | 2010 | 3035 | 0.130 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2015 | 10 | 0.130 |
Why?
|
| Frail Elderly | 2 | 2012 | 696 | 0.130 |
Why?
|
| Noise | 1 | 2018 | 282 | 0.130 |
Why?
|
| DNA, Mitochondrial | 1 | 2021 | 836 | 0.130 |
Why?
|
| Hypoventilation | 1 | 2015 | 38 | 0.130 |
Why?
|
| Longevity | 1 | 2023 | 1085 | 0.130 |
Why?
|
| Population Surveillance | 4 | 2004 | 2618 | 0.130 |
Why?
|
| HIV Infections | 5 | 2022 | 16882 | 0.130 |
Why?
|
| Meat | 1 | 2019 | 589 | 0.130 |
Why?
|
| Lung Diseases | 4 | 2014 | 1890 | 0.130 |
Why?
|
| Antigens, Nuclear | 1 | 2016 | 193 | 0.130 |
Why?
|
| Academies and Institutes | 2 | 2020 | 320 | 0.130 |
Why?
|
| Perimenopause | 1 | 2017 | 143 | 0.130 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 980 | 0.130 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2008 | 2444 | 0.130 |
Why?
|
| Pilot Projects | 5 | 2022 | 8413 | 0.130 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2016 | 76 | 0.130 |
Why?
|
| Peptide Fragments | 4 | 2020 | 5124 | 0.130 |
Why?
|
| Ankle Brachial Index | 2 | 2015 | 155 | 0.130 |
Why?
|
| Minnesota | 4 | 2014 | 344 | 0.130 |
Why?
|
| Computer Simulation | 8 | 2023 | 6190 | 0.130 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2015 | 112 | 0.130 |
Why?
|
| Otolaryngology | 1 | 2002 | 653 | 0.130 |
Why?
|
| Gadolinium | 1 | 2020 | 959 | 0.130 |
Why?
|
| Pregnant Women | 1 | 2020 | 576 | 0.130 |
Why?
|
| Dilatation | 2 | 2012 | 303 | 0.130 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2015 | 45 | 0.130 |
Why?
|
| Dyssomnias | 1 | 2014 | 29 | 0.130 |
Why?
|
| Automobile Driving | 1 | 2020 | 430 | 0.130 |
Why?
|
| Pain Perception | 1 | 2016 | 191 | 0.120 |
Why?
|
| Lipid Metabolism | 4 | 2021 | 1883 | 0.120 |
Why?
|
| Maternal Age | 1 | 2018 | 810 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2024 | 1068 | 0.120 |
Why?
|
| Air Pollutants | 3 | 2010 | 2861 | 0.120 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2014 | 59 | 0.120 |
Why?
|
| Secondary Prevention | 1 | 2021 | 1553 | 0.120 |
Why?
|
| Period Circadian Proteins | 1 | 2015 | 98 | 0.120 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 855 | 0.120 |
Why?
|
| Memory | 2 | 2001 | 2188 | 0.120 |
Why?
|
| Neonatal Screening | 1 | 1999 | 589 | 0.120 |
Why?
|
| Television | 2 | 2014 | 406 | 0.120 |
Why?
|
| Creatinine | 4 | 2024 | 1893 | 0.120 |
Why?
|
| Societies, Medical | 6 | 2019 | 3802 | 0.120 |
Why?
|
| Sexual Partners | 1 | 2019 | 743 | 0.120 |
Why?
|
| Awareness | 1 | 2018 | 643 | 0.120 |
Why?
|
| Respiratory System | 3 | 2008 | 556 | 0.120 |
Why?
|
| Blood Vessels | 1 | 2020 | 1127 | 0.120 |
Why?
|
| Cicatrix | 1 | 2020 | 774 | 0.120 |
Why?
|
| Editorial Policies | 1 | 2019 | 458 | 0.120 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2017 | 259 | 0.120 |
Why?
|
| Respiratory Mechanics | 3 | 1998 | 696 | 0.120 |
Why?
|
| Information Storage and Retrieval | 2 | 2011 | 827 | 0.120 |
Why?
|
| Risk | 8 | 2020 | 9683 | 0.120 |
Why?
|
| Heart | 2 | 2023 | 4458 | 0.120 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2014 | 119 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2022 | 1788 | 0.120 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2016 | 231 | 0.120 |
Why?
|
| Kidney | 3 | 2022 | 7152 | 0.120 |
Why?
|
| Environmental Pollutants | 1 | 2023 | 1230 | 0.120 |
Why?
|
| Cardiomyopathies | 3 | 2014 | 1895 | 0.120 |
Why?
|
| Estrogen Replacement Therapy | 3 | 2018 | 1217 | 0.110 |
Why?
|
| Educational Status | 3 | 2016 | 2573 | 0.110 |
Why?
|
| Censuses | 1 | 2015 | 202 | 0.110 |
Why?
|
| Lung Diseases, Obstructive | 3 | 1989 | 313 | 0.110 |
Why?
|
| Serine Endopeptidases | 1 | 2019 | 1084 | 0.110 |
Why?
|
| Health Services Accessibility | 3 | 2023 | 5222 | 0.110 |
Why?
|
| Oxygen Consumption | 3 | 2016 | 1874 | 0.110 |
Why?
|
| Data Mining | 1 | 2018 | 543 | 0.110 |
Why?
|
| Double-Blind Method | 6 | 2024 | 12202 | 0.110 |
Why?
|
| Physicians | 2 | 2023 | 4625 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2019 | 0.110 |
Why?
|
| Tidal Volume | 1 | 2015 | 494 | 0.110 |
Why?
|
| Brain Infarction | 3 | 2022 | 299 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2021 | 3753 | 0.110 |
Why?
|
| Risk-Taking | 1 | 2019 | 990 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 2 | 2020 | 2729 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2012 | 370 | 0.110 |
Why?
|
| CLOCK Proteins | 1 | 2013 | 86 | 0.110 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2015 | 475 | 0.110 |
Why?
|
| Genealogy and Heraldry | 1 | 2012 | 28 | 0.110 |
Why?
|
| Software | 2 | 2021 | 4460 | 0.110 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2010 | 1973 | 0.110 |
Why?
|
| Genetic Markers | 2 | 2016 | 2633 | 0.110 |
Why?
|
| Drug Resistance | 1 | 2019 | 1603 | 0.110 |
Why?
|
| Psychomotor Performance | 1 | 2001 | 1878 | 0.110 |
Why?
|
| Lod Score | 2 | 2004 | 611 | 0.110 |
Why?
|
| Temperature | 2 | 2017 | 2233 | 0.110 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 1089 | 0.110 |
Why?
|
| Cholesterol | 3 | 2019 | 2926 | 0.110 |
Why?
|
| Reproduction | 1 | 2017 | 673 | 0.110 |
Why?
|
| Environmental Exposure | 3 | 2024 | 4344 | 0.110 |
Why?
|
| Mobility Limitation | 2 | 2014 | 413 | 0.110 |
Why?
|
| Confidence Intervals | 6 | 2018 | 2978 | 0.110 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2012 | 67 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2020 | 2987 | 0.110 |
Why?
|
| Visual Perception | 1 | 2001 | 1419 | 0.110 |
Why?
|
| Menopause | 2 | 2018 | 1641 | 0.110 |
Why?
|
| Research Personnel | 1 | 2017 | 578 | 0.110 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2010 | 600 | 0.110 |
Why?
|
| Lipocalins | 1 | 2013 | 164 | 0.110 |
Why?
|
| ras Proteins | 1 | 2018 | 1065 | 0.110 |
Why?
|
| Advisory Committees | 2 | 2014 | 779 | 0.110 |
Why?
|
| Oxidative Stress | 3 | 2016 | 3131 | 0.110 |
Why?
|
| ARNTL Transcription Factors | 1 | 2013 | 98 | 0.110 |
Why?
|
| Health | 1 | 2015 | 394 | 0.110 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2022 | 1362 | 0.110 |
Why?
|
| Africa | 3 | 2021 | 696 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2019 | 2846 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2004 | 321 | 0.100 |
Why?
|
| Fibroblast Growth Factors | 1 | 2018 | 880 | 0.100 |
Why?
|
| Muscles | 3 | 1987 | 1618 | 0.100 |
Why?
|
| Vasoconstriction | 1 | 2015 | 596 | 0.100 |
Why?
|
| Sympathetic Nervous System | 2 | 2012 | 513 | 0.100 |
Why?
|
| Observer Variation | 3 | 2011 | 2622 | 0.100 |
Why?
|
| Death, Sudden | 1 | 2014 | 310 | 0.100 |
Why?
|
| Hyperthyroidism | 1 | 2014 | 296 | 0.100 |
Why?
|
| Mental Health | 2 | 2022 | 3074 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 2 | 2021 | 1554 | 0.100 |
Why?
|
| Models, Biological | 3 | 2019 | 9569 | 0.100 |
Why?
|
| Connexin 43 | 1 | 2012 | 205 | 0.100 |
Why?
|
| Urbanization | 1 | 2012 | 101 | 0.100 |
Why?
|
| Chronobiology Disorders | 1 | 2012 | 72 | 0.100 |
Why?
|
| Depressive Disorder, Major | 2 | 2021 | 4692 | 0.100 |
Why?
|
| Influenza, Human | 1 | 2023 | 1515 | 0.100 |
Why?
|
| Puerto Rico | 3 | 2020 | 360 | 0.100 |
Why?
|
| Diet, Mediterranean | 1 | 2018 | 729 | 0.100 |
Why?
|
| Drosophila melanogaster | 1 | 2021 | 1730 | 0.100 |
Why?
|
| User-Computer Interface | 1 | 2018 | 1432 | 0.100 |
Why?
|
| Entropy | 2 | 2011 | 212 | 0.100 |
Why?
|
| Respiratory Tract Diseases | 1 | 2017 | 727 | 0.100 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2012 | 152 | 0.100 |
Why?
|
| Genetic Pleiotropy | 2 | 2022 | 181 | 0.100 |
Why?
|
| Anti-Asthmatic Agents | 3 | 2011 | 551 | 0.100 |
Why?
|
| Laboratories | 1 | 2015 | 466 | 0.100 |
Why?
|
| Crossing Over, Genetic | 1 | 2011 | 95 | 0.100 |
Why?
|
| Heart Atria | 1 | 2017 | 1356 | 0.100 |
Why?
|
| Maternal Mortality | 1 | 2014 | 313 | 0.100 |
Why?
|
| Industry | 1 | 2013 | 365 | 0.100 |
Why?
|
| Quality Control | 3 | 2021 | 839 | 0.100 |
Why?
|
| Pulmonary Emphysema | 1 | 2016 | 679 | 0.100 |
Why?
|
| Mood Disorders | 1 | 1998 | 1115 | 0.100 |
Why?
|
| Apolipoproteins | 1 | 2013 | 315 | 0.100 |
Why?
|
| Databases, Genetic | 5 | 2021 | 1780 | 0.100 |
Why?
|
| Homosexuality, Male | 1 | 2019 | 1247 | 0.100 |
Why?
|
| Leukocytes | 1 | 2019 | 2056 | 0.100 |
Why?
|
| Vascular Diseases | 2 | 2016 | 1160 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 1127 | 0.100 |
Why?
|
| Gene Expression | 5 | 2019 | 7771 | 0.100 |
Why?
|
| Low Back Pain | 1 | 2019 | 965 | 0.090 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2015 | 416 | 0.090 |
Why?
|
| Healthcare Disparities | 3 | 2017 | 3218 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2023 | 20346 | 0.090 |
Why?
|
| Clinical Competence | 2 | 2013 | 4729 | 0.090 |
Why?
|
| Vocabulary, Controlled | 1 | 2011 | 170 | 0.090 |
Why?
|
| Emphysema | 1 | 2013 | 246 | 0.090 |
Why?
|
| Pain | 3 | 2021 | 5040 | 0.090 |
Why?
|
| Environment Design | 1 | 2012 | 180 | 0.090 |
Why?
|
| Muscle Proteins | 2 | 2019 | 1160 | 0.090 |
Why?
|
| Fatigue | 2 | 2013 | 1536 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 1708 | 0.090 |
Why?
|
| Respiratory Muscles | 1 | 1991 | 139 | 0.090 |
Why?
|
| Methacholine Chloride | 1 | 2010 | 233 | 0.090 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2010 | 65 | 0.090 |
Why?
|
| Transducers | 1 | 2011 | 251 | 0.090 |
Why?
|
| Acute Coronary Syndrome | 1 | 2023 | 2348 | 0.090 |
Why?
|
| Myocardial Ischemia | 2 | 1998 | 2152 | 0.090 |
Why?
|
| Leg | 1 | 2015 | 1123 | 0.090 |
Why?
|
| Texas | 2 | 2016 | 395 | 0.090 |
Why?
|
| Activity Cycles | 1 | 2010 | 50 | 0.090 |
Why?
|
| Death | 1 | 2014 | 675 | 0.090 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 3686 | 0.090 |
Why?
|
| Proteomics | 1 | 2023 | 3686 | 0.090 |
Why?
|
| Emotions | 1 | 2022 | 2684 | 0.090 |
Why?
|
| Women's Health | 1 | 2019 | 2059 | 0.090 |
Why?
|
| Women | 1 | 2011 | 232 | 0.090 |
Why?
|
| Mathematical Computing | 1 | 2009 | 147 | 0.090 |
Why?
|
| Bone Density | 2 | 2020 | 3504 | 0.090 |
Why?
|
| Health Resources | 1 | 2016 | 920 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 3069 | 0.090 |
Why?
|
| Chronic Disease | 6 | 2016 | 9223 | 0.090 |
Why?
|
| Health Promotion | 2 | 2022 | 2210 | 0.090 |
Why?
|
| Nasal Cavity | 1 | 2012 | 314 | 0.090 |
Why?
|
| Critical Care | 2 | 2020 | 2696 | 0.090 |
Why?
|
| Lipoproteins, LDL | 1 | 2012 | 642 | 0.090 |
Why?
|
| Receptors, Serotonin | 1 | 2010 | 202 | 0.090 |
Why?
|
| Boston | 2 | 2021 | 9348 | 0.090 |
Why?
|
| Mothers | 4 | 2022 | 2190 | 0.080 |
Why?
|
| Estradiol | 1 | 2017 | 2025 | 0.080 |
Why?
|
| Nose | 2 | 2018 | 511 | 0.080 |
Why?
|
| Sexual Behavior | 1 | 2019 | 2072 | 0.080 |
Why?
|
| Fractures, Bone | 2 | 2013 | 1991 | 0.080 |
Why?
|
| Infant Mortality | 1 | 2014 | 763 | 0.080 |
Why?
|
| Mexico | 1 | 2011 | 723 | 0.080 |
Why?
|
| Growth Charts | 1 | 2009 | 63 | 0.080 |
Why?
|
| Hypothyroidism | 1 | 2014 | 670 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2016 | 1447 | 0.080 |
Why?
|
| Body Composition | 3 | 2021 | 2439 | 0.080 |
Why?
|
| Sodium Channels | 1 | 2011 | 348 | 0.080 |
Why?
|
| Nutrition Surveys | 3 | 2023 | 1684 | 0.080 |
Why?
|
| Acromegaly | 1 | 2012 | 348 | 0.080 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 1687 | 0.080 |
Why?
|
| Monocytes | 1 | 2018 | 2602 | 0.080 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2011 | 630 | 0.080 |
Why?
|
| Hearing Loss | 1 | 2016 | 775 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 6493 | 0.080 |
Why?
|
| Molecular Sequence Annotation | 2 | 2021 | 529 | 0.080 |
Why?
|
| DNA Methylation | 2 | 2019 | 4315 | 0.080 |
Why?
|
| Central America | 2 | 2020 | 68 | 0.080 |
Why?
|
| Goals | 1 | 2014 | 716 | 0.080 |
Why?
|
| Aorta | 1 | 2016 | 2063 | 0.080 |
Why?
|
| Homeodomain Proteins | 2 | 2015 | 2423 | 0.080 |
Why?
|
| Acetates | 1 | 2009 | 312 | 0.080 |
Why?
|
| Renal Dialysis | 2 | 2008 | 1749 | 0.080 |
Why?
|
| Lipoproteins, HDL | 1 | 2012 | 659 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2023 | 35798 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 2013 | 448 | 0.080 |
Why?
|
| Mitochondria | 1 | 2021 | 3555 | 0.080 |
Why?
|
| Saliva | 3 | 2017 | 805 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2018 | 2912 | 0.080 |
Why?
|
| South America | 2 | 2020 | 181 | 0.080 |
Why?
|
| Androstadienes | 1 | 2009 | 344 | 0.080 |
Why?
|
| Lung Volume Measurements | 2 | 2018 | 378 | 0.080 |
Why?
|
| Medication Adherence | 2 | 2009 | 2099 | 0.080 |
Why?
|
| Renin-Angiotensin System | 1 | 2012 | 759 | 0.080 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 1459 | 0.080 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2008 | 106 | 0.080 |
Why?
|
| Internal-External Control | 1 | 2009 | 364 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2011 | 395 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2022 | 4194 | 0.070 |
Why?
|
| Migraine Disorders | 1 | 2019 | 1645 | 0.070 |
Why?
|
| Data Compression | 1 | 2008 | 71 | 0.070 |
Why?
|
| Arteriosclerosis | 2 | 2005 | 1090 | 0.070 |
Why?
|
| Thyroid Gland | 1 | 2014 | 1180 | 0.070 |
Why?
|
| E-Selectin | 2 | 2024 | 579 | 0.070 |
Why?
|
| Genetic Heterogeneity | 1 | 2010 | 733 | 0.070 |
Why?
|
| Animals | 13 | 2023 | 169600 | 0.070 |
Why?
|
| Mutagenesis | 2 | 2021 | 1257 | 0.070 |
Why?
|
| Contrast Media | 1 | 2020 | 5338 | 0.070 |
Why?
|
| Birth Weight | 3 | 2021 | 2099 | 0.070 |
Why?
|
| Epidemiologic Methods | 2 | 2008 | 1366 | 0.070 |
Why?
|
| Crohn Disease | 1 | 2019 | 2321 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2020 | 283 | 0.070 |
Why?
|
| Adiponectin | 1 | 2012 | 1108 | 0.070 |
Why?
|
| Beverages | 2 | 2022 | 818 | 0.070 |
Why?
|
| Computer Security | 1 | 2008 | 263 | 0.070 |
Why?
|
| Vitamin D Deficiency | 1 | 2015 | 1367 | 0.070 |
Why?
|
| Bronchial Provocation Tests | 3 | 2010 | 227 | 0.070 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1986 | 175 | 0.070 |
Why?
|
| Diaphragm | 1 | 1987 | 354 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 2888 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2013 | 2454 | 0.060 |
Why?
|
| Energy Metabolism | 2 | 2015 | 2908 | 0.060 |
Why?
|
| Survival Rate | 4 | 2020 | 12802 | 0.060 |
Why?
|
| Neoplasm Proteins | 2 | 2015 | 3700 | 0.060 |
Why?
|
| Nursing Evaluation Research | 1 | 2004 | 26 | 0.060 |
Why?
|
| Thromboembolism | 1 | 2011 | 996 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 2009 | 1262 | 0.060 |
Why?
|
| Diabetes Complications | 2 | 2005 | 1356 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 2 | 2008 | 2499 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 2 | 2020 | 1071 | 0.060 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 1127 | 0.060 |
Why?
|
| Nursing Homes | 1 | 2012 | 1044 | 0.060 |
Why?
|
| Oropharynx | 1 | 2005 | 127 | 0.060 |
Why?
|
| Forecasting | 2 | 2013 | 2956 | 0.060 |
Why?
|
| Probability | 3 | 2011 | 2514 | 0.060 |
Why?
|
| Nursing Assessment | 1 | 2004 | 107 | 0.060 |
Why?
|
| Quinolines | 1 | 2009 | 746 | 0.060 |
Why?
|
| Mutagenesis, Insertional | 1 | 2007 | 654 | 0.060 |
Why?
|
| Chicago | 1 | 2004 | 241 | 0.060 |
Why?
|
| Pain, Postoperative | 1 | 2014 | 1678 | 0.060 |
Why?
|
| Bone and Bones | 1 | 2015 | 2597 | 0.060 |
Why?
|
| Siblings | 1 | 2008 | 850 | 0.060 |
Why?
|
| Anaerobiosis | 1 | 2023 | 140 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2022 | 1231 | 0.060 |
Why?
|
| Titanium | 1 | 1986 | 493 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2008 | 747 | 0.060 |
Why?
|
| Haptoglobins | 1 | 2005 | 167 | 0.060 |
Why?
|
| Self-Assessment | 1 | 2006 | 389 | 0.060 |
Why?
|
| Enteroendocrine Cells | 1 | 2024 | 66 | 0.060 |
Why?
|
| Mutation | 6 | 2024 | 29981 | 0.060 |
Why?
|
| Tongue | 1 | 1986 | 405 | 0.060 |
Why?
|
| Confidentiality | 1 | 2008 | 614 | 0.060 |
Why?
|
| Interleukin-10 | 1 | 2009 | 1205 | 0.060 |
Why?
|
| Chronotherapy | 1 | 2022 | 11 | 0.060 |
Why?
|
| Attitude to Health | 2 | 2009 | 2058 | 0.060 |
Why?
|
| Likelihood Functions | 2 | 2020 | 1010 | 0.060 |
Why?
|
| Body Fat Distribution | 2 | 2014 | 244 | 0.050 |
Why?
|
| HIV-1 | 1 | 2020 | 6981 | 0.050 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2023 | 85 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3136 | 0.050 |
Why?
|
| Sensory Receptor Cells | 1 | 1987 | 498 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2005 | 801 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3246 | 0.050 |
Why?
|
| K562 Cells | 1 | 2024 | 641 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2019 | 4290 | 0.050 |
Why?
|
| DNA Primase | 1 | 2022 | 109 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2022 | 49 | 0.050 |
Why?
|
| Cities | 2 | 2018 | 518 | 0.050 |
Why?
|
| Trees | 1 | 2022 | 58 | 0.050 |
Why?
|
| Metalloproteases | 1 | 2022 | 61 | 0.050 |
Why?
|
| Chromosome Deletion | 1 | 2007 | 1400 | 0.050 |
Why?
|
| Gene Expression Regulation | 4 | 2024 | 12054 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7355 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2002 | 314 | 0.050 |
Why?
|
| Equipment Design | 1 | 2010 | 3589 | 0.050 |
Why?
|
| Membrane Proteins | 4 | 2021 | 7941 | 0.050 |
Why?
|
| Colorectal Neoplasms | 2 | 2013 | 6855 | 0.050 |
Why?
|
| Self Concept | 2 | 2008 | 1033 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2021 | 4179 | 0.050 |
Why?
|
| Massachusetts | 4 | 2020 | 8721 | 0.050 |
Why?
|
| Informed Consent | 2 | 2023 | 1000 | 0.050 |
Why?
|
| Loss of Heterozygosity | 1 | 2024 | 683 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2006 | 674 | 0.050 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2023 | 217 | 0.050 |
Why?
|
| Glycerol | 1 | 2022 | 280 | 0.050 |
Why?
|
| Action Potentials | 2 | 2020 | 1807 | 0.050 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 1203 | 0.050 |
Why?
|
| Chromatin | 2 | 2024 | 2960 | 0.050 |
Why?
|
| Apnea | 1 | 2002 | 194 | 0.050 |
Why?
|
| Respiration, Artificial | 2 | 2020 | 2611 | 0.050 |
Why?
|
| Skin Tests | 2 | 2000 | 621 | 0.050 |
Why?
|
| Occlusal Splints | 1 | 2020 | 19 | 0.050 |
Why?
|
| Nervous System Diseases | 1 | 2012 | 1636 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2021 | 182 | 0.050 |
Why?
|
| Glucose | 3 | 2022 | 4396 | 0.050 |
Why?
|
| Caveolin 1 | 1 | 2022 | 262 | 0.050 |
Why?
|
| alpha Karyopherins | 1 | 2020 | 41 | 0.050 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2020 | 33 | 0.050 |
Why?
|
| School Health Services | 1 | 2004 | 380 | 0.050 |
Why?
|
| Janus Kinase 2 | 1 | 2024 | 533 | 0.050 |
Why?
|
| South Australia | 1 | 2020 | 18 | 0.050 |
Why?
|
| Pediatrics | 1 | 2016 | 3517 | 0.050 |
Why?
|
| Population Groups | 1 | 2021 | 208 | 0.050 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2021 | 105 | 0.050 |
Why?
|
| Subcutaneous Tissue | 1 | 2021 | 135 | 0.050 |
Why?
|
| Pennsylvania | 2 | 2014 | 612 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3871 | 0.050 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2020 | 72 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2023 | 798 | 0.050 |
Why?
|
| Population Density | 1 | 2021 | 196 | 0.050 |
Why?
|
| Osteopontin | 1 | 2022 | 301 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 1867 | 0.050 |
Why?
|
| Sweden | 1 | 2023 | 1348 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2020 | 2901 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2014 | 5367 | 0.040 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2008 | 1005 | 0.040 |
Why?
|
| Parity | 1 | 2023 | 948 | 0.040 |
Why?
|
| Hospitals | 1 | 2023 | 3986 | 0.040 |
Why?
|
| Recurrence | 2 | 2022 | 8422 | 0.040 |
Why?
|
| Patient Positioning | 1 | 2022 | 324 | 0.040 |
Why?
|
| Plethysmography | 2 | 2011 | 180 | 0.040 |
Why?
|
| Adenoma | 1 | 2010 | 2182 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2021 | 281 | 0.040 |
Why?
|
| Homeostasis | 1 | 2010 | 3343 | 0.040 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2021 | 340 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3304 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2022 | 600 | 0.040 |
Why?
|
| Caspase 9 | 1 | 2019 | 180 | 0.040 |
Why?
|
| Receptors, Vasopressin | 1 | 2019 | 111 | 0.040 |
Why?
|
| Japan | 1 | 2003 | 1377 | 0.040 |
Why?
|
| Telomerase | 1 | 2024 | 734 | 0.040 |
Why?
|
| Aortic Diseases | 1 | 2005 | 740 | 0.040 |
Why?
|
| Recombinases | 1 | 2019 | 68 | 0.040 |
Why?
|
| Paris | 1 | 2018 | 42 | 0.040 |
Why?
|
| Calcium | 2 | 2023 | 5774 | 0.040 |
Why?
|
| Albuterol | 2 | 2009 | 209 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2005 | 1127 | 0.040 |
Why?
|
| Virulence | 1 | 2022 | 1328 | 0.040 |
Why?
|
| Epigenomics | 1 | 2024 | 905 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2020 | 333 | 0.040 |
Why?
|
| Nasal Decongestants | 1 | 1998 | 28 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 9431 | 0.040 |
Why?
|
| Receptors, Nicotinic | 2 | 2012 | 498 | 0.040 |
Why?
|
| Paranasal Sinus Diseases | 1 | 1999 | 120 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2017 | 32 | 0.040 |
Why?
|
| Data Collection | 1 | 2007 | 3350 | 0.040 |
Why?
|
| Health Priorities | 1 | 2021 | 381 | 0.040 |
Why?
|
| Airway Resistance | 2 | 1989 | 402 | 0.040 |
Why?
|
| Occupational Diseases | 1 | 1986 | 1471 | 0.040 |
Why?
|
| Antiporters | 1 | 2019 | 279 | 0.040 |
Why?
|
| Licensure | 1 | 1998 | 124 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2020 | 650 | 0.040 |
Why?
|
| Acute Chest Syndrome | 1 | 2018 | 31 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2019 | 372 | 0.040 |
Why?
|
| Mental Disorders | 2 | 2016 | 6699 | 0.040 |
Why?
|
| Pulmonary Embolism | 2 | 2014 | 2481 | 0.040 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2017 | 59 | 0.040 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2000 | 338 | 0.040 |
Why?
|
| Hypocapnia | 1 | 1997 | 39 | 0.040 |
Why?
|
| Acculturation | 1 | 2019 | 181 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2024 | 1351 | 0.040 |
Why?
|
| Policy | 1 | 2021 | 516 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2021 | 648 | 0.040 |
Why?
|
| Sickle Cell Trait | 1 | 2018 | 86 | 0.040 |
Why?
|
| Clinical Protocols | 2 | 2015 | 1463 | 0.040 |
Why?
|
| Germ Cells | 1 | 2021 | 645 | 0.040 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 5380 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 4420 | 0.040 |
Why?
|
| Testosterone | 1 | 2008 | 2457 | 0.040 |
Why?
|
| Phenylalanine | 1 | 2018 | 367 | 0.040 |
Why?
|
| Psychotropic Drugs | 1 | 2023 | 893 | 0.040 |
Why?
|
| Fourier Analysis | 2 | 2008 | 441 | 0.040 |
Why?
|
| Culture | 1 | 2021 | 636 | 0.040 |
Why?
|
| Health Policy | 2 | 2021 | 2687 | 0.040 |
Why?
|
| Adipocytes | 1 | 2024 | 1193 | 0.040 |
Why?
|
| Administration, Inhalation | 2 | 2010 | 1129 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2024 | 976 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2021 | 792 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2023 | 1119 | 0.040 |
Why?
|
| CpG Islands | 1 | 2021 | 1219 | 0.040 |
Why?
|
| Condoms | 1 | 2019 | 322 | 0.040 |
Why?
|
| Pressure | 3 | 1991 | 1207 | 0.040 |
Why?
|
| Survival Analysis | 3 | 2019 | 10252 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2021 | 23512 | 0.040 |
Why?
|
| Troponin I | 1 | 2021 | 622 | 0.040 |
Why?
|
| Amylases | 1 | 2016 | 172 | 0.040 |
Why?
|
| Hydroxyurea | 1 | 2018 | 288 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2018 | 4943 | 0.030 |
Why?
|
| Stillbirth | 1 | 2019 | 352 | 0.030 |
Why?
|
| Australia | 1 | 2020 | 1168 | 0.030 |
Why?
|
| Sensation | 2 | 1991 | 339 | 0.030 |
Why?
|
| Monitoring, Physiologic | 3 | 1993 | 1750 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 2022 | 867 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2018 | 15459 | 0.030 |
Why?
|
| Oocytes | 1 | 2021 | 1193 | 0.030 |
Why?
|
| Medical Records | 2 | 2018 | 1412 | 0.030 |
Why?
|
| Phylogeography | 1 | 2016 | 81 | 0.030 |
Why?
|
| Intelligence | 1 | 2001 | 919 | 0.030 |
Why?
|
| Metabolome | 1 | 2023 | 921 | 0.030 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2020 | 302 | 0.030 |
Why?
|
| Allergens | 2 | 2000 | 1339 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 1436 | 0.030 |
Why?
|
| Atrophy | 1 | 2020 | 1600 | 0.030 |
Why?
|
| Therapeutic Equipoise | 1 | 2015 | 28 | 0.030 |
Why?
|
| Respiration Disorders | 1 | 1999 | 370 | 0.030 |
Why?
|
| Consanguinity | 1 | 2017 | 459 | 0.030 |
Why?
|
| Cold Temperature | 2 | 1989 | 773 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2000 | 813 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2018 | 665 | 0.030 |
Why?
|
| Automation | 1 | 2018 | 583 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 2019 | 550 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2008 | 2112 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2006 | 2297 | 0.030 |
Why?
|
| beta-Thalassemia | 1 | 2018 | 226 | 0.030 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2021 | 606 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 979 | 0.030 |
Why?
|
| Random Allocation | 1 | 2020 | 2426 | 0.030 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2011 | 3661 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2022 | 1670 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2021 | 1151 | 0.030 |
Why?
|
| Echocardiography | 2 | 2020 | 5117 | 0.030 |
Why?
|
| Chile | 1 | 2015 | 242 | 0.030 |
Why?
|
| Remission, Spontaneous | 1 | 2015 | 388 | 0.030 |
Why?
|
| Housing | 1 | 2020 | 673 | 0.030 |
Why?
|
| Spouses | 1 | 2017 | 286 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2019 | 1426 | 0.030 |
Why?
|
| Translating | 1 | 2016 | 149 | 0.030 |
Why?
|
| Palate, Soft | 2 | 1996 | 101 | 0.030 |
Why?
|
| Death Certificates | 1 | 2015 | 172 | 0.030 |
Why?
|
| Antidepressive Agents | 3 | 2016 | 2863 | 0.030 |
Why?
|
| Brazil | 1 | 2019 | 1288 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2004 | 2129 | 0.030 |
Why?
|
| DNA Replication | 1 | 2021 | 1407 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 689 | 0.030 |
Why?
|
| Disability Evaluation | 2 | 2014 | 1842 | 0.030 |
Why?
|
| Bradycardia | 1 | 2016 | 307 | 0.030 |
Why?
|
| Bundle-Branch Block | 1 | 2016 | 271 | 0.030 |
Why?
|
| Education | 1 | 2017 | 543 | 0.030 |
Why?
|
| Acid Ceramidase | 1 | 2013 | 20 | 0.030 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1994 | 139 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2016 | 456 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 3901 | 0.030 |
Why?
|
| Sex Ratio | 1 | 1994 | 109 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2019 | 847 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2023 | 2559 | 0.030 |
Why?
|
| Factor V | 1 | 2014 | 180 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 1084 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2019 | 1118 | 0.030 |
Why?
|
| Hypnotics and Sedatives | 2 | 2011 | 1177 | 0.030 |
Why?
|
| Rehabilitation | 1 | 2014 | 133 | 0.030 |
Why?
|
| Iron | 1 | 2022 | 1786 | 0.030 |
Why?
|
| Terminology as Topic | 2 | 2011 | 1547 | 0.030 |
Why?
|
| Spine | 1 | 2020 | 1127 | 0.030 |
Why?
|
| Ventilators, Negative-Pressure | 1 | 1992 | 13 | 0.030 |
Why?
|
| Indians, North American | 1 | 2017 | 352 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2228 | 0.030 |
Why?
|
| Psychology | 1 | 2015 | 357 | 0.030 |
Why?
|
| Occupational Health Services | 1 | 2014 | 153 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 820 | 0.030 |
Why?
|
| Peru | 1 | 2016 | 901 | 0.030 |
Why?
|
| Medicare | 2 | 2022 | 6670 | 0.030 |
Why?
|
| Cadherins | 1 | 2017 | 900 | 0.030 |
Why?
|
| Neurofibrillary Tangles | 1 | 2014 | 441 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 2033 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 2017 | 993 | 0.030 |
Why?
|
| Hysterectomy | 1 | 2018 | 945 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2016 | 880 | 0.030 |
Why?
|
| Age of Onset | 1 | 2018 | 3290 | 0.030 |
Why?
|
| Safety | 1 | 2017 | 1179 | 0.030 |
Why?
|
| Physical Fitness | 1 | 2016 | 732 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2013 | 288 | 0.030 |
Why?
|
| Foundations | 1 | 2011 | 93 | 0.020 |
Why?
|
| Baroreflex | 1 | 2012 | 146 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2023 | 5858 | 0.020 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2012 | 115 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2013 | 309 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2015 | 6050 | 0.020 |
Why?
|
| Perception | 1 | 2018 | 1199 | 0.020 |
Why?
|
| DNA Damage | 1 | 2021 | 2442 | 0.020 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2011 | 54 | 0.020 |
Why?
|
| Africa, Western | 1 | 2011 | 159 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2022 | 4806 | 0.020 |
Why?
|
| Bone Remodeling | 1 | 2015 | 578 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 3491 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2024 | 3518 | 0.020 |
Why?
|
| Autopsy | 1 | 2014 | 1024 | 0.020 |
Why?
|
| Interleukin-11 | 1 | 2010 | 65 | 0.020 |
Why?
|
| Teaching | 1 | 1998 | 1176 | 0.020 |
Why?
|
| Asymptomatic Diseases | 1 | 2013 | 560 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2012 | 257 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2011 | 211 | 0.020 |
Why?
|
| P-Selectin | 1 | 2013 | 601 | 0.020 |
Why?
|
| Physical Education and Training | 1 | 1991 | 106 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 2 | 2008 | 2160 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2014 | 855 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2010 | 182 | 0.020 |
Why?
|
| Plaque, Amyloid | 1 | 2014 | 743 | 0.020 |
Why?
|
| Disease Management | 1 | 2021 | 2473 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 2015 | 981 | 0.020 |
Why?
|
| New York City | 1 | 2012 | 719 | 0.020 |
Why?
|
| Muscular Dystrophies | 1 | 1992 | 393 | 0.020 |
Why?
|
| Health Services Research | 1 | 2018 | 1838 | 0.020 |
Why?
|
| Mandible | 2 | 1996 | 744 | 0.020 |
Why?
|
| Atrioventricular Node | 1 | 2011 | 183 | 0.020 |
Why?
|
| Affect | 1 | 1998 | 1478 | 0.020 |
Why?
|
| Geographic Information Systems | 1 | 2012 | 280 | 0.020 |
Why?
|
| Altruism | 1 | 2011 | 204 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2011 | 6542 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2016 | 1175 | 0.020 |
Why?
|
| Total Quality Management | 1 | 2011 | 274 | 0.020 |
Why?
|
| Mice | 3 | 2023 | 81766 | 0.020 |
Why?
|
| Genes | 1 | 2013 | 1885 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2010 | 420 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2013 | 366 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 9664 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2013 | 1160 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2012 | 834 | 0.020 |
Why?
|
| Sulfides | 1 | 2009 | 167 | 0.020 |
Why?
|
| Sinusitis | 1 | 1998 | 948 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2014 | 920 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 938 | 0.020 |
Why?
|
| International Cooperation | 1 | 2015 | 1439 | 0.020 |
Why?
|
| Vasodilation | 1 | 2013 | 946 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2017 | 2332 | 0.020 |
Why?
|
| Prenatal Care | 1 | 1996 | 1106 | 0.020 |
Why?
|
| Body Temperature | 1 | 1991 | 770 | 0.020 |
Why?
|
| Anti-Allergic Agents | 1 | 2009 | 142 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2014 | 2642 | 0.020 |
Why?
|
| Cyclopropanes | 1 | 2009 | 414 | 0.020 |
Why?
|
| T-Box Domain Proteins | 1 | 2011 | 480 | 0.020 |
Why?
|
| Maximal Expiratory Flow-Volume Curves | 1 | 1987 | 25 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2002 | 13042 | 0.020 |
Why?
|
| Physical Examination | 1 | 2014 | 1237 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 4562 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2009 | 345 | 0.020 |
Why?
|
| Placebo Effect | 1 | 2012 | 504 | 0.020 |
Why?
|
| Adipose Tissue | 2 | 2011 | 3308 | 0.020 |
Why?
|
| Social Support | 1 | 2017 | 2145 | 0.020 |
Why?
|
| Language | 1 | 2017 | 1506 | 0.020 |
Why?
|
| Helium | 1 | 1987 | 124 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 7708 | 0.020 |
Why?
|
| Cystatin C | 1 | 2008 | 253 | 0.020 |
Why?
|
| Decision Making | 1 | 2001 | 3909 | 0.020 |
Why?
|
| Awards and Prizes | 1 | 2011 | 377 | 0.020 |
Why?
|
| Systems Biology | 1 | 2011 | 477 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 675 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2014 | 2580 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2011 | 603 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2023 | 4624 | 0.020 |
Why?
|
| Occupational Health | 1 | 2013 | 807 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2010 | 680 | 0.020 |
Why?
|
| Metallurgy | 1 | 1986 | 94 | 0.020 |
Why?
|
| ROC Curve | 1 | 1994 | 3558 | 0.020 |
Why?
|
| Tracheotomy | 1 | 1987 | 166 | 0.020 |
Why?
|
| Biomedical Engineering | 1 | 2008 | 294 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2010 | 936 | 0.020 |
Why?
|
| Liver | 1 | 2021 | 7538 | 0.020 |
Why?
|
| Particle Size | 1 | 2010 | 1648 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1991 | 1232 | 0.020 |
Why?
|
| Vagus Nerve | 1 | 2008 | 446 | 0.020 |
Why?
|
| Red-Cell Aplasia, Pure | 1 | 1985 | 30 | 0.020 |
Why?
|
| Hand Strength | 1 | 2008 | 457 | 0.020 |
Why?
|
| Program Development | 1 | 2011 | 1314 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2005 | 211 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2020 | 6647 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 6364 | 0.020 |
Why?
|
| Phenytoin | 1 | 1985 | 199 | 0.020 |
Why?
|
| Markov Chains | 1 | 2008 | 979 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2010 | 1485 | 0.010 |
Why?
|
| Body Constitution | 1 | 2004 | 279 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 18174 | 0.010 |
Why?
|
| Postural Balance | 1 | 2008 | 621 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2014 | 4216 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2016 | 5103 | 0.010 |
Why?
|
| Myocardium | 1 | 2016 | 4719 | 0.010 |
Why?
|
| Geriatrics | 1 | 2008 | 398 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 2004 | 381 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2011 | 2502 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2014 | 4598 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2011 | 1947 | 0.010 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 1985 | 323 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2015 | 6037 | 0.010 |
Why?
|
| Mycoses | 1 | 1985 | 389 | 0.010 |
Why?
|
| Brachial Artery | 1 | 2003 | 368 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2014 | 3487 | 0.010 |
Why?
|
| Neurons | 1 | 2021 | 9439 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 6169 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 2003 | 463 | 0.010 |
Why?
|
| Venous Thromboembolism | 1 | 2013 | 1770 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8607 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2019 | 6923 | 0.010 |
Why?
|
| Base Sequence | 1 | 2011 | 12769 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 2005 | 1013 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 2004 | 797 | 0.010 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2004 | 740 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2009 | 2738 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 18050 | 0.010 |
Why?
|
| Mites | 1 | 1997 | 45 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2009 | 1950 | 0.010 |
Why?
|
| Cockroaches | 1 | 1997 | 96 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2005 | 1879 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2010 | 3573 | 0.010 |
Why?
|
| Hyoid Bone | 1 | 1996 | 38 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 11091 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1996 | 229 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1986 | 5552 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 2275 | 0.010 |
Why?
|
| Nitrogen Dioxide | 1 | 1997 | 500 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2002 | 1270 | 0.010 |
Why?
|
| Dust | 1 | 1997 | 485 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2006 | 2555 | 0.010 |
Why?
|
| Emergency Service, Hospital | 2 | 2006 | 7766 | 0.010 |
Why?
|
| Ontario | 1 | 1994 | 386 | 0.010 |
Why?
|
| Hematocrit | 1 | 1994 | 636 | 0.010 |
Why?
|
| Darkness | 1 | 1992 | 160 | 0.010 |
Why?
|
| Maximal Midexpiratory Flow Rate | 1 | 1992 | 78 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 5725 | 0.010 |
Why?
|
| Radiographic Image Enhancement | 1 | 1996 | 886 | 0.010 |
Why?
|
| Rhode Island | 1 | 1991 | 348 | 0.010 |
Why?
|
| Head | 1 | 1996 | 898 | 0.010 |
Why?
|
| Tracheostomy | 1 | 1992 | 408 | 0.010 |
Why?
|
| Equipment Failure | 1 | 1991 | 579 | 0.010 |
Why?
|
| Malassezia | 1 | 1985 | 8 | 0.000 |
Why?
|
| Respiratory Insufficiency | 1 | 1992 | 1211 | 0.000 |
Why?
|
| Erythropoiesis | 1 | 1985 | 706 | 0.000 |
Why?
|
| Bone Marrow Cells | 1 | 1985 | 2491 | 0.000 |
Why?
|
| Intracranial Aneurysm | 1 | 1985 | 1206 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1985 | 4575 | 0.000 |
Why?
|